References
- Yu L, Reutzel-Edens SM, Mitchell CA. Crystallization and polymorphism of conformationally flexible molecules: problems, patterns, and strategies. Org Process Res Dev 2000;4:396–402.
- Nagai K, Ushio T, Miura H, et al. Four new polymorphic forms of suplatast tosilate. Int J Pharm 2014;460:83–91.
- Li Y, Chow PS, Tan RBH. Quantification of polymorphic impurity in an enantiotropic polymorph system using differential scanning calorimetry, X-ray powder diffraction and Raman spectroscopy. Int J Pharm 2011;415:110–118.
- Ashizawa K. Polymorphism and crystal structure of 2R,4S,6-fluoro-2-methyl-spiro[chroman-4,4′-imidazoline]-2′,5-dione (M79175). J Pharm Sci 1989;78:256–260.
- Elguero J. Polymorphism and desmotropy in heterocyclic crystal structures. Cryst Growth Des 2011;11:4731–4738.
- Vega D, Petragalli A, Fernández D, Ellena JA. Polymorphism on leflunomide: stability and crystal structures. J Pharm Sci 2006;95:1075–1083.
- Threlfall TL. Analysis of organic polymorphs – a review. Analyst 1995;120:2435–2460.
- Dong Z Jr, Young V, Sheth A, et al. Crystal structure of neotame anhydrate polymorph G. Pharm Res 2002;19:1549–1553.
- Dimitris P, PapadopoulosMD F, Vasilios Papademetriou MFF. Metoprolol succinate combination in the treatment of hypertension. Angiology 2009;60:608–613.
- Price CP, Grzesiak AL, Matzger AJ. Crystalline polymorph selection and discovery with polymer heteronuclei. J Am Chem Soc 2005;127:5512–5517.
- Lang M, Grzesiak AL, Matzger AJ. The use of polymer heteronuclei for crystalline polymorph selection. J Am Chem Soc 2002;124:14834–14835.
- Zhang GGZ, Gu C, Zell MT, et al. Crystallization and transitions of sulfamerazine polymorphs. J Pharm Sci 2002;91:1089–1100.
- Zhang G, Gao L, Zhang Z, et al. Heating-induced phase transition of bupropion hydrobromide polymorphs. J Pharm Sci 2012;101:3091–3095.
- Appelgen CH, Eskilsson EC. Pharmaceutical composition comprising metroprolol succinate. US 5001161; 1988
- Grunenberg A, Henck JO, Siesler HW. Theoretical derivation and practical application of energy/temperature diagrams as an instrument in preformulation studies of polymorphic drug substances. Int J Pharm 1996;129:147–158.